NCT02473640View on ClinicalTrials.gov

A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy Volunteers With Ileostomy
Interventions
DRUG

SYN-004

DRUG

Esomeprazole

DRUG

Ceftriaxone

Trial Locations (2)

Unknown

Synthetic Biologics Investigative Site, Edmonton

Synthetic Biologics Investigative Site, Montreal

All Listed Sponsors
lead

Theriva Biologics, Inc.

INDUSTRY

NCT02473640 - A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy | Biotech Hunter | Biotech Hunter